| Followers | 202 |
| Posts | 25627 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Wednesday, November 08, 2023 1:37:45 AM
1) the crossover was not post box and the rescue to the trial, it was part of the trial from the beginning. You really are confused HyGro.
2) the ECA was because the cross ver depleted the actual placebo arm as a regulator would expect if a drug was working. 90% of the patients got the drug and everyone was living longer than normal, not a situation that would suggest a failed trial in that instance;
3) the trial was allowed to run many years because survival was obvious yes, everyone was living longer. But they yes also knew pseudoprogression was an issue in many immunotherapy trials. But they still did not know the results and were not unblinded. Further, the independent consultants who drew up the SAP were not involved with the trial and only knew the clinical trials description and parameters, so that was an extra level of blindness upon blindness. But was not post hoc, but ironically trials that are post hoc still get approved, so it’s an irrelevant point. This was not that, but your claim is nothing meaningful at this stage.
So no, I did not “miss anything”.
The independents who wrote up the trial then did a study of the results compared to the ECA on exactly the measures you suggest and found across the board, statistically, there is no bias due to the factors you suggest. Further, from the beginning they considered all of the differences you suggest and picked the most representative and concurrently similar clinical trials. There statistical analysis proved that there is no such bias.
Hence, you must articulate and speculate about bias but there is none… it’s all speculation and your anxiety because you have been consistently wrong across the board.
Your poorly thought out posts are so hateful and unreal. You really should spend some time away from your computer. You write almost like poor gollum speaks, the way you get so intense.
That shorts generally and so anxiously want such an admirable breakthrough kept from these suffering patients is just an incredible memorial to the bankruptcy of the soul of every short. I can’t imagine, where they are going with this insanity, but it will not be a very nice place, ultimately.
2) the ECA was because the cross ver depleted the actual placebo arm as a regulator would expect if a drug was working. 90% of the patients got the drug and everyone was living longer than normal, not a situation that would suggest a failed trial in that instance;
3) the trial was allowed to run many years because survival was obvious yes, everyone was living longer. But they yes also knew pseudoprogression was an issue in many immunotherapy trials. But they still did not know the results and were not unblinded. Further, the independent consultants who drew up the SAP were not involved with the trial and only knew the clinical trials description and parameters, so that was an extra level of blindness upon blindness. But was not post hoc, but ironically trials that are post hoc still get approved, so it’s an irrelevant point. This was not that, but your claim is nothing meaningful at this stage.
So no, I did not “miss anything”.
The independents who wrote up the trial then did a study of the results compared to the ECA on exactly the measures you suggest and found across the board, statistically, there is no bias due to the factors you suggest. Further, from the beginning they considered all of the differences you suggest and picked the most representative and concurrently similar clinical trials. There statistical analysis proved that there is no such bias.
Hence, you must articulate and speculate about bias but there is none… it’s all speculation and your anxiety because you have been consistently wrong across the board.
Your poorly thought out posts are so hateful and unreal. You really should spend some time away from your computer. You write almost like poor gollum speaks, the way you get so intense.
That shorts generally and so anxiously want such an admirable breakthrough kept from these suffering patients is just an incredible memorial to the bankruptcy of the soul of every short. I can’t imagine, where they are going with this insanity, but it will not be a very nice place, ultimately.
I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
